ErbB4 mutations have been described to occur in lung, breast, gastric cancer and melanoma and like for ErbB3 differ from those observed in EGFR or HER2 by not displaying characteristic mutational hotspots. This evidence concerns the gene ERBB3 and gastric cancer.